3 Fast-Growing Medical REITs At Attractive Prices

Happy millennial indian lady doctor in coat with phonendoscope raises hands and shows fingers up

Prostock-Studio/iStock via Getty Images

Thanks to the sell-off in REITs this year, there are a number of strong Medical REITs on sale at attractive prices. Hoya Capital Income Builder makes it easy to spot them.

Although Medical REITs have slightly outperformed the REIT average this year (see chart below), that isn’t saying much, since the average total return for the REIT sector overall YTD is a dismal (-26.01%).

List of 18 REIT sectors, showing Healthcare running in 8th place, with a return of (-24.97)%

Hoya Capital Income Builder

Amid the carnage, the average Yield for the sector has soared to 4.93%, and the average Price/FFO has fallen to just 15.7. Yet there are three Healthcare REITs showing strong growth in revenue and cash flow, that are available at even more attractive prices. Still more remarkably, while most Medical REITs were forced to cut or suspend dividends in response to the COVID crisis, all three of these companies maintained or increased their dividends.

This article spotlights growth, balance sheet, dividend, and valuation metrics for Medical Properties Trust (MPW), Community Healthcare Trust (CHCT), and Global Medical REIT (GMRE).

Medical Properties Trust

company logo

Medical Properties Trust

Established in 2003 and headquartered in Birmingham, Alabama, MPW owns 434 properties, primarily hospitals (80%), leased to 54 tenants in 10 countries, primarily in the U.S. and Europe. MPW is the second-largest non-governmental owner of hospitals in the world.

map of globe, showing heavy concentration of MPW assets in U.S. and Europe, with small numbers in South America and Australia

Medical Properties Trust website

The company develops new hospitals as well as acquiring, expanding, and renovating existing ones.

pie chart showing data as described in text.

Medical Properties Trust website

The core of MPW’s business model is unlocking the value of hospital real estate for growth, through two mechanisms:

  1. Sale/Leaseback
  2. Investments in hospital operators

This allows hospital operators to improve their financial positions, gain liquidity, reduce taxes, and increase operating flexibility, all while maintaining control over the facility. The weighted average lease is an ultra-lengthy 17.6 years.

pie chart showing MPW asset mix: over 70% general acute hospitals, 10-13% behavior health facilities, 9% inpatient rehab facilities, 11% other

Medical Properties Trust website

Latest quarterly returns showed Adjusted FFO up 6.9% YoY, (5.9% on a per-share basis), and net income per share attributable to stockholders up 27.5%.

The biggest knock against MPW is a lack of diversification in its tenant roster. Its largest tenant accounts for 29.5% of Q3 2022 revenues, and its top 5 account for 58.5%, making the health and success of these operators crucial to MPW’s results.

table of data as described in text

Q3 2022 Earnings Supplemental for Medical Properties Trust

Growth

Although the rate of growth in revenues for MPW slowed sharply this year, and cash flow backpedaled, the 3-year growth rates are FROG-worthy double digits across the board, and continued sizzling, right through the pandemic.

Metric 2019 2020 2021 2022* 3-year CAGR
FFO (millions) $536 $758 $976 $1075
FFO Growth % 41.4 28.8 10.1 26.1%
FFO per share $1.30 $1.57 $1.75 $1.81
FFO per share growth % 20.8 11.5 3.4 11.7%
TCFO (millions) $494 $618 $812 $744
TCFO Growth % 25.1 31.4 (-8.4) 14.6%

*Projected, based on Q3 2022 results

Balance sheet

MPW’s balance sheet is bond rated, but the company’s debt ratio is a little high at 45%. Its liquidity of 1.86, coupled with its double-digit growth rates, qualifies Medical Properties Trust as a bona fide FROG. The weighted average interest rate on the company’s debt is 3.463%, with maturities building to a peak in 2026.

Company Liquidity Ratio Debt Ratio Debt/EBITDA Bond Rating
MPW 1.86 45% 6.6 BB+
Medical REIT avg 2.02 30% 7.4
Overall REIT avg 1.90 25% 6.2

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

Dividends

MPW pays an inflation-beating 9.83% yield. The company’s 3-year dividend growth rate of 4.4% is far better than the Medical REIT average, and the Dividend Score of 11.19 is nothing short of sensational. With a payout ratio of 60%, the Dividend Safety score assigned by Seeking Alpha Premium is a picture perfect C+.

Company Div. Yield 3-yr Div. Growth Div. Score Payout Div. Safety
MPW 9.83 4.4% 11.19 60% C+
Medical REITs 4.93 (-4.3)% 4.32 70% C
REITs overall 3.86 6.3% 4.61 59% C

Source: Hoya Capital Income Builder, TD Ameritrade, Seeking Alpha Premium

Dividend Score projects the Yield three years from now, on shares bought today, assuming the Dividend Growth rate remains unchanged.

Valuation

At a Price/FFO ratio of just 6.5, and a 27.6% discount to NAV, Medical Properties Trust is dirt cheap.

Company Div. Score Price/FFO ’22 Premium to NAV
MPW 11.19 6.5 (-27.6)%
Medical REIT average 4.32 15.7 (- 2.9)%
Overall REIT average 4.61 17.1 (-15.0)%

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

Bottom line: MPW

MPW offers a practically irresistible combination of strong growth, inflation-beating dividends that are unlikely to be cut, and dirt cheap price.

Community Healthcare Trust

company logo

Community Healthcare Trust

Founded in 2014, and headquartered in Franklin, Tennessee, small-cap CHCT owns over 160 medical facilities totaling some 35 msf (million square feet) spread across 34 U.S. states, currently enjoying 90.8% occupancy.

map of U.S., showing CHCT assets most concentrated in Texas and Illinois, along with Ohio and Florida, but spread across 34 states, including all but 3 of those east of the Mississippi River

CHCT website

About 30% of CHCT’s revenue comes from MOBs (medical office buildings), with 16% from AIBs (acute inpatient behavior facilities), and another 19% from IRFs (inpatient rehab facilities). The full breakdown is shown below.

pie chart and table, depicting data as described in text.

CHCT Q3 2022 Earnings Supplemental

The core of CHCT’s business model is leveraging the personal relationships between the management team and a wide array of medical providers, built up over many years in the medical real estate business, to discover off-market or lightly-marketed acquisition opportunities in secondary markets. Thus, they avoid competitive bidding and secure properties at favorable prices, resulting in cap rates well above average.

Latest quarterly results for CHCT show FFO up 4.0% from Q3 2021 (3.6% on per-share basis), and AFFO up 7.2% (6.8% per share), according to the company’s Q3 2022 earnings supplemental. Rental income is up 6.5% and NOI (net operating income) is up 6.7% (5.0% per share). Adjusted EBITDAre is up 6.6%. The company has added a net $53 million worth of properties thru the first nine months of this year, bringing the total portfolio value to $890 million. This is a significantly slower pace than in previous years, but still solid, given the interest rate environment.

The biggest knock against CHCT is its occupancy rate, which was expected to stabilize in the low 90’s, but at times has dipped into the high 80’s, with significant consequences for internal growth. Tenant diversification is also far from ideal, with the top two tenants accounting for 20% of ABR.

pie chart depicting data as described in text

CHCT Q3 2022 Earnings Supplemental

Growth

Like MPW, the revenue and cash flow growth rates for CHCT have slowed significantly this year, but the 3-year growth rates remain FROG-worthy double digits. CHCT kept growing, right through the pandemic.

Metric 2019 2020 2021 2022* 3-year CAGR
FFO (millions) $32.1 $45.0 $52.9 $54.7
FFO Growth % 40.2 17.6 3.4 19.4%
FFO per share $1.67 $2.04 $2.35 $2.27
FFO per share growth % 22.2 15.2 (-3.4) 10.8%
TCFO (millions) $32.4 $48.4 $56.3 $59.8
TCFO Growth % 49.4 16.3 6.2 22.7%

*Projected, based on Q3 2022 results

Balance sheet

CHCT maintains a superb all-weather balance sheet, with excellent liquidity and ultra-low debt. But for its small size, CHCT would be a FROG. So I classify it as a Tadpole until it reaches $1.4 billion in market cap.

Company Liquidity Ratio Debt Ratio Debt/EBITDA Bond Rating
CHCT 2.44 18% 4.7

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

The weighted average interest rate on CHCT’s revolving line of credit balance of $307 million is 4.47%, and 3.79% on its term loans. The company faces no maturities in 2023, 2025, or 2027.

bar chart showing $55 million due in 2024, $132 million in 2026and balance in 2028 or thereafter

CHCT Q3 2022 Earnings Supplemental

Dividends

CHCT pays a fatter-than-average 5.08%, and despite a payout ratio of 80%, the dividend gets a safety grade of B- from Seeking Alpha Premium. This company has raised its dividend a quarter of a penny every quarter of its existence, like clockwork.

Company Div. Yield 3-yr Div. Growth Div. Score Payout Div. Safety
CHCT 5.08 2.5% 5.47 80% B-

Source: Hoya Capital Income Builder, TD Ameritrade, Seeking Alpha Premium

Valuation

Growth like CHCT has shown usually comes at a high price tag. However, the current Price/FFO on this company is now 15.5, slightly below both the Medical REIT and overall REIT averages.

Company Div. Score Price/FFO ’22 Premium to NAV
CHCT 5.47 15.5 0.2%

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

Bottom line: CHCT

CHCT offers an interesting combination of above-average yield and below-average price, with a balance sheet ready for any conditions, and a dividend almost guaranteed to remain the same or increase.

Global Medical REIT

company logo

Global Medical REIT

Global Medical REIT is a small-cap net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases them to healthcare systems and physician groups with leading market share. The company owns 189 properties totaling 4.9 msf (million square feet), leased to 269 tenants. The weighted average lease term is 6.4 years, and the weighted average cap rate for all acquisitions is a tasty 7.7%.

The top 10 tenants account for only 36% of ABR.

bar chart showing percent of ABR from each of top 10 tenants. Largest is under 7%

Company website

About two-thirds (67.3%) of GMRE’s assets are MOBs (medical office buildings). Rehab facilities make up about one-sixth (17.5%).

pie chart, showing asset type allocation as described in text.

Company website

The company does not focus on any particular geographic area. Texas and Florida lead the way with 18% and 10% of ABR, respectively.

map of U.S., showing assets spread across 37 states, mostly in the eastern and southern halves

Company Q3 2022 supplemental

pie chart, showing geographical distribution as described in text

Company website

The core of GMRE’s business model is using a network of referral agents to locate off-market opportunities with price tags between $5-$20 million, and a highly disciplined selection process, seeking characteristics that will drive occupancy and profitability, targeting $200 million in annual acquisitions. Through September 30, they are right on schedule, with $149 million in 14 acquisitions totaling 583,000 leasable square feet.

According to the company’s latest 10-Q, in Q3 2022, GMRE reported revenues up 18.1% from Q3 a year ago, and net income up 118%, thanks largely to some timely and profitable dispositions. FFO was up 2.4%, and AFFO ticked up 4.2%. EBITDAre rose 11.4%, with adjusted EBITDAre up 10.4%. Cash from operations for the first 9 months was up 12.7% YoY.

The biggest knock against GMRE is the financial soundness of its tenant base. However, this company is diligent in vetting its tenants, so any such risk is Medical sector-wide, and not confined only to GMRE.

Growth

GMRE’s revenue and cash flow took a step back during COVID, but more than made up for lost time in 2021, before settling back toward more normal FROG-worthy double-digit rates this year.

Metric 2019 2020 2021 2022* 3-year CAGR
FFO (millions) $28.4 $28.0 $58.2 $64.8
FFO Growth % (-1.4) 107.9 11.3 19.1%
FFO per share $0.75 $0.56 $0.90 $0.93
FFO per share growth % (-25.3) 60.7 3.33 7.4%
TCFO (millions) $36.4 $34.5 $69.0 $77.6
TCFO Growth % (-5.2) 100.0 12.5 28.7%

*Projected, based on Q3 2022 results

Balance sheet

GMRE’s balance sheet is neither weak nor particularly strong, coming in almost dead average on liquidity, debt ratio, and Debt/EBITDA. Like CHCT, GMRE is a Tadpole.

Company Liquidity Ratio Debt Ratio Debt/EBITDA Bond Rating
GMRE 1.90 30% 7.4

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

GMRE’s debts totaled $635 million as of September 30.

Dividends

Global Medical REIT pays an inflation-beating 8.38% yield. Although its 90% payout ratio and Dividend Safety rating of D look risky, in fact this company maintained or increased its dividend, right through the pandemic, and ever since, with similar Dividend Safety ratings.

Company Div. Yield 3-yr Div. Growth Div. Score Payout Div. Safety
GMRE 8.38 1.6 8.79 90% D

Source: Hoya Capital Income Builder, TD Ameritrade, Seeking Alpha Premium

Valuation

Given its growth rate and robust dividends, GMRE sells at a surprisingly low Price/FFO of 10.7, and a 16.5% discount to NAV.

Company Div. Score Price/FFO ’22 Premium to NAV
GMRE 8.79 10.7 (-16.5)%

Source: Hoya Capital Income Builder, TD Ameritrade, and author calculations

Bottom line: GMRE

GMRE offers a hard-to-resist combination of inflation-beating yield, with dividends that are likely to remain the same or increase, all at an attractive price.

Be the first to comment

Leave a Reply

Your email address will not be published.


*